Two decades of progress in glioma methylation research: the rise of temozolomide resistance and immunotherapy insights
The findings of this study illustrate the increasing scholarly interest in glioma methylation, with a notable increase in research output over the past two decades. This study provides a comprehensive overview of the research landscape, highlighting the importance of temozolomide, DNA methylation, and the tumor microenvironment in glioma research. Despite its limitations, this study offers valuable insights into the current research trends and potential future directions, particularly in the realm of immunotherapy and epigenetic editing techniques.
Authors
- Xiangmei Cao (ORCID: https://orcid.org/0000-0001-5231-4288)
- Xianhao Huo (ORCID: https://orcid.org/0000-0002-2612-8390)
- Lijuan Song (ORCID: https://orcid.org/0000-0003-2945-5669)
- Fang Du (ORCID: https://orcid.org/0000-0002-4814-8739)
- Pengfei Chen (ORCID: https://orcid.org/0000-0002-0090-3475)
- Haoyuan Li (ORCID: https://orcid.org/0000-0001-5741-1917)
- Wenqing Liu (ORCID: https://orcid.org/0000-0001-8613-3119)
- Jihui Tian
- Yixiang Xing
- Zhenhua Yu
Institutions
- Ningxia University (CN)
- Ningxia Medical University (CN)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2024-09-02
- DOI
- https://doi.org/10.3389/fnins.2024.1440756
- Citations
- 2
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.88
Funders
- Ningxia Medical University
- Natural Science Foundation of Ningxia Province
- Key Research and Development Program of Ningxia